Clinical Trial Update: Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure [Phase 2]

View source ↗

Summary

This is a multicentre, placebo-controlled, double-blind Phase II trial evaluating lenvatinib in patients with locally advanced or metastatic gastrointestinal st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Lenvatinib (lenvatinib)

Snippet

Sponsor: Centre Leon Berard | Conditions: Gastro Intestinal Stromal Tumour | Phase 2 | Status: COMPLETED